You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 834 Retinoid X receptor agonists enhances type I systemic and intratumoral immunity, but enhanced tumor prevention, with the HER2-IGFBP2-IGF1R plasmid vaccine in two mouse mammary tumor models

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
834 Retinoid X receptor agonists enhances type I systemic and intratumoral immunity, but enhanced tumor prevention, with the HER2-IGFBP2-IGF1R plasmid vaccine in two mouse mammary tumor models

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023148012
Dec 20232605
Jan 20242901
Feb 20243403
Mar 20241803
Apr 20242200
May 20242000
Jun 20241400
Jul 20241201
Aug 20241202
Sep 20242202
Oct 2024605
Nov 20241005
Dec 20241603
Jan 20252207
Feb 2025503
Mar 2025004
Apr 2025002
May 2025003
Jun 2025102
Total417063